Hoth Therapeutics (HOTH) News Today → Bitcoin’s Biggest Year Yet (From Paradigm Press) (Ad) Free HOTH Stock Alerts $1.22 +0.06 (+5.17%) (As of 05/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23 at 8:00 PM | finance.yahoo.comHoth Therapeutics, Inc. (HOTH) Stock Price, News, Quote & History - Yahoo FinanceMay 15, 2024 | investorplace.comHOTH Stock Earnings: Hoth Therapeutics Misses EPS for Q1 2024May 1, 2024 | prnewswire.comHoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024April 12, 2024 | msn.comHoth Therapeutics files to sell 5.03M shares of common stock for holdersApril 2, 2024 | msn.comThe Brickyard, Carlisle to welcome popular rock band Elias T HothMarch 27, 2024 | prnewswire.comHoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsMarch 27, 2024 | prnewswire.comHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity TreatmentMarch 19, 2024 | marketwatch.comHoth Therapeutics Shares Soar on Positive Data from Alzheimer's StudyMarch 19, 2024 | msn.comWhy Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?March 19, 2024 | finanznachrichten.deHoth Therapeutics, Inc.: Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZMarch 19, 2024 | msn.comGraphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare moversMarch 19, 2024 | markets.businessinsider.comHoth Therapeutics: Pre-clinical Research Shows HT-ALZ's Profound Impact On Alzheimer's PathologyMarch 19, 2024 | msn.comHoth stock rallies 24% on preclinical Alzheimer's dataMarch 19, 2024 | prnewswire.comHoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZFebruary 29, 2024 | finance.yahoo.comHoth Therapeutics Retains Venable LLP to Expand Its Patent PortfolioFebruary 26, 2024 | finanznachrichten.deHoth Therapeutics, Inc.: Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting TherapeuticFebruary 26, 2024 | markets.businessinsider.comHoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer TreatmentFebruary 26, 2024 | prnewswire.comHoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting TherapeuticFebruary 13, 2024 | finance.yahoo.comHoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024February 6, 2024 | markets.businessinsider.comBuy Rating for Hoth Therapeutics: Promising HT-001 Prospects and Diverse Clinical PipelineJanuary 18, 2024 | finanznachrichten.deHoth Therapeutics, Inc.: Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill PatientsJanuary 18, 2024 | markets.businessinsider.comHoth Therapeutics Received FDA Clearance To Broaden HT-001 Clinical TrialJanuary 18, 2024 | marketwatch.comHoth Therapeutics Shares Rise 14% After FDA Clearance for HT-001 Trial AmendmentsJanuary 18, 2024 | msn.comHoth stock jumps on FDA approval of study expansion for HT-001January 18, 2024 | finance.yahoo.comHoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill PatientsDecember 27, 2023 | msn.comHoth Therapeutics, SCWorx among healthcare moversDecember 27, 2023 | msn.comWhy Hoth Therapeutics Shares Are Rising TodayDecember 27, 2023 | finance.yahoo.comHoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of MiamiDecember 22, 2023 | morningstar.comHoth Therapeutics Inc Ordinary Shares HOTHDecember 12, 2023 | morningstar.comHoth Therapeutics Inc Ordinary SharesDecember 5, 2023 | finance.yahoo.comHoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling StudiesNovember 14, 2023 | markets.businessinsider.comHoth Completes Pre-IND Meeting With FDA On Development Of HT-KIT TherapeuticNovember 14, 2023 | finance.yahoo.comHoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KITNovember 10, 2023 | finance.yahoo.comHoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023October 5, 2023 | finance.yahoo.comHoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug DiscoveryOctober 2, 2023 | markets.businessinsider.comHoth Therapeutics: FDA Grants Pre-IND Meeting For HT-KIT; Stock SurgesOctober 2, 2023 | finance.yahoo.comFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer PatientsSeptember 15, 2023 | nasdaq.comEF Hutton Maintains Hoth Therapeutics (HOTH) Buy RecommendationSeptember 15, 2023 | finance.yahoo.comHoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesSeptember 13, 2023 | markets.businessinsider.comHoth Therapeutics Reports Positive Preclinical Results Of HT-KIT Therapeutic; Stock SurgesSeptember 13, 2023 | marketwatch.comHoth Therapeutics Shares Rise 7% After Positive Study Data for HT-KITSeptember 13, 2023 | msn.comHoth stock tumbles on $2.9M direct offering, private placementSeptember 13, 2023 | marketwatch.comHoth Therapeutics Shares Drop 23% After Direct Offering PricesSeptember 13, 2023 | msn.comHoth Therapeutics' Investigational Cancer Drug Shows Encouraging Preclinical Activity In Stomach CancersSeptember 13, 2023 | finance.yahoo.comHoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaSeptember 13, 2023 | finance.yahoo.comHoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesSeptember 11, 2023 | markets.businessinsider.comHoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDASeptember 11, 2023 | finance.yahoo.comHoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer PatientsSeptember 6, 2023 | markets.businessinsider.comHoth Therapeutics Reports Positive Results From Phase 1b Trial Of BioLexaSeptember 6, 2023 | finance.yahoo.comHoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. HOTH Media Mentions By Week HOTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOTH News Sentiment▼0.940.78▲Average Medical News Sentiment HOTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOTH Articles This Week▼21▲HOTH Articles Average Week Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lipella Pharmaceuticals News Adial Pharmaceuticals News Kineta News Lixte Biotechnology News Genprex News Enveric Biosciences News Sonnet BioTherapeutics News Protagenic Therapeutics News First Wave BioPharma News Xenetic Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOTH) was last updated on 5/26/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s PRIME is Set to Shock the WorldInvestorPlaceShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis could mean the end of the U.S dollar…Colonial MetalsJust $9 for a Year of Winning Market InsightsBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeNew Options need New Trading StrategiesNetpicks$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.